Sensus Healthcare, Inc. (SRTS) vs TELA Bio, Inc. (TELA)
A side-by-side comparison of Sensus Healthcare, Inc. and TELA Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SRTS
Sensus Healthcare, Inc.
$2.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TELA
TELA Bio, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SRTS vs TELA
growth of $100 · dividends reinvested · last 7ySRTS -27.2% (-4.4%/yr)TELA -91.5% (-29.6%/yr)SRTS compounded faster over this window
Log scale — wide-divergence pair
SRTS TELA
SRTS vs TELA: by the numbers
- •SRTS is the larger company ($49M vs $49M market cap).
- •Both run net losses; TELA's is the smaller (-51.53% vs -88.45% net margin).
- •TELA grew revenue faster over the past five years (26.77% vs 2.86% CAGR).
Metrics side by side
Valuation
| Metric | SRTS | TELA |
|---|---|---|
| P/S ratio | 2.79 | 0.61 |
| P/B ratio | 1.33 | N/A |
Profitability
| Metric | SRTS | TELA |
|---|---|---|
| Gross margin | 36.39% | 67.81% |
| Operating margin | -37.50% | -42.56% |
| Net margin | -88.45% | -51.53% |
| ROE | -42.01% | N/A |
| ROIC | -35.63% | -80.88% |
Growth (annualized)
| Metric | SRTS | TELA |
|---|---|---|
| Revenue CAGR (5Y) | 2.86% | 26.77% |
| Total return CAGR (5Y) | -4.37% | -38.71% |
Frequently asked
- Which has grown faster, SRTS or TELA?
- Over the past five years, TELA grew revenue faster — SRTS at a 2.86% CAGR versus TELA at 26.77%.
- How have SRTS and TELA total returns compared?
- Over the past 5 years, SRTS delivered -4.37% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Sensus Healthcare ROETELA Bio ROESensus Healthcare operating marginTELA Bio operating marginSensus Healthcare revenue growthTELA Bio revenue growthSensus Healthcare free cash flowTELA Bio free cash flow
Sensus Healthcare & TELA Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.